Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review

Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH82632FSA
  • |
  • Pages: 43
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hybrigenics S.A. (ALHYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hybrigenics S.A. (Hybrigenics) offers research and development of new targets and therapies against proliferative cancerous or non-cancerous diseases. Its lead product candidate is inecalcitol, which is a vitamin D receptor agonist being assessed for various cancer indications including prostate cancer, chronic lymphocytic leukaemia and moderate to severe psoriasis. Hybrigenics research program investigates the action of deubiquitinating enzymes (DUB) in the recycling of onco-proteins and the utility of proprietary patented DUB inhibitors against various cancer indications. The company has expertise in the field of DUBs, which it applies to the discovery and development of new treatments. Hybrigenics Services, the company's subsidiary, markets specialized scientific services that aid in validating and inhibiting protein interactions in animal, plant or microbiological cells. Hybrigenics is headquartered in Paris, France.

Hybrigenics S.A. Key Recent Developments

Apr 25, 2016: Hybrigenics full year 2015 results

Nov 16, 2015: Hybrigenics set up an international Clinical Advisory Board

Oct 19, 2015: Hybrigenics 2015 first-half results and highlights

Jul 27, 2015: Hybrigenics first half 2015 revenues and cash

Jul 01, 2015: New appointments within Hybrigenics' Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1 - About the Company 6

Hybrigenics S.A. - Key Facts 6

Hybrigenics S.A. - Key Employees 7

Hybrigenics S.A. - Key Employee Biographies 8

Hybrigenics S.A. - Major Products and Services 9

Hybrigenics S.A. - Pharmaceutical Pipeline Products Data 10

Hybrigenics S.A., Pipeline Products by Therapy Area 10

Hybrigenics S.A., Pipeline Products by Development Phase 11

Hybrigenics S.A. - History 13

Hybrigenics S.A. - Company Statement 15

Hybrigenics S.A. - Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2 - Company Analysis 17

Hybrigenics S.A. - Business Description 17

Hybrigenics S.A. - Corporate Strategy 18

Hybrigenics S.A. - SWOT Analysis 19

SWOT Analysis - Overview 19

Hybrigenics S.A. - Strengths 19

Strength - Research Expertise 19

Strength - Integrated Network 19

Hybrigenics S.A. - Weaknesses 20

Weakness - History of Losses 20

Weakness - Competitive Positioning 20

Hybrigenics S.A. - Opportunities 21

Opportunity - Market Potential: Cancer Treatments 21

Opportunity - Orphan Drug Designation 21

Opportunity - Strategic Partnerships 21

Hybrigenics S.A. - Threats 22

Threat - Competition and Technological Change 22

Threat - Uncertain R&D Outcomes 22

Threat - Government Regulations 22

Hybrigenics S.A. - Key Competitors 23

Section 3 - Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 26

Financial Performance 26

Financial Ratios - Interim Ratios 27

Financial Ratios - Ratio Charts 28

Section 4 - Company's Lifesciences Financial Deals and Alliances 29

Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 29

Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 30

Hybrigenics S.A., Recent Deals Summary 31

Section 5 - Company's Recent Developments 32

Apr 25, 2016: Hybrigenics full year 2015 results 32

Nov 16, 2015: Hybrigenics set up an international Clinical Advisory Board 33

Oct 19, 2015: Hybrigenics 2015 first-half results and highlights 34

Jul 27, 2015: Hybrigenics first half 2015 revenues and cash 35

Jul 01, 2015: New appointments within Hybrigenics' Board of Directors 36

Apr 27, 2015: Hybrigenics full year 2014 results 37

Feb 02, 2015: Hybrigenics 2014 revenues and cash 38

Section 6 - Appendix 39

Methodology 39

Ratio Definitions 39

About GlobalData 43

Contact Us 43

Disclaimer 43

List of Figures

Hybrigenics S.A., Pipeline Products by Therapy Area 10

Hybrigenics S.A., Pipeline Products by Development Phase 11

Hybrigenics S.A., Performance Chart (2011 - 2015) 26

Hybrigenics S.A., Ratio Charts 28

Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 29

Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 30

List of Tables

Hybrigenics S.A., Key Facts 6

Hybrigenics S.A., Key Employees 7

Hybrigenics S.A., Key Employee Biographies 8

Hybrigenics S.A., Major Products and Services 9

Hybrigenics S.A., Number of Pipeline Products by Therapy Area 10

Hybrigenics S.A., Number of Pipeline Products by Development Stage 11

Hybrigenics S.A., Pipeline Products By Therapy Area and Development Phase 12

Hybrigenics S.A., History 13

Hybrigenics S.A., Subsidiaries 16

Hybrigenics S.A., Key Competitors 23

Hybrigenics S.A., Ratios based on current share price 24

Hybrigenics S.A., Annual Ratios 25

Hybrigenics S.A., Interim Ratios 27

Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 29

Hybrigenics S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 30

Hybrigenics S.A., Recent Deals Summary 31

Currency Codes 39

Capital Market Ratios 39

Equity Ratios 40

Profitability Ratios 40

Cost Ratios 41

Liquidity Ratios 41

Leverage Ratios 42

Efficiency Ratios 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Vaxon Biotech

Transgene SA

Quantum Genomics SA

Qiagen Marseille SA

Innate Pharma S.A.

Erytech Pharma SA

Bioquanta SA

select a license

Single User License
USD 125 INR 8010
Site License
USD 250 INR 16020
Corporate User License
USD 375 INR 24030

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com